198 related articles for article (PubMed ID: 7645989)
1. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
[TBL] [Abstract][Full Text] [Related]
2. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
3. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
Colcher D; Milenic DE; Ferroni P; Carrasquillo JA; Reynolds JC; Roselli M; Larson SM; Schlom J
J Nucl Med; 1990 Jul; 31(7):1133-42. PubMed ID: 2362192
[TBL] [Abstract][Full Text] [Related]
4. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
Thor A; Ohuchi N; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1986 Jun; 46(6):3118-24. PubMed ID: 3516392
[TBL] [Abstract][Full Text] [Related]
5. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models.
DePalatis LR; Johnson KA; Kaplan DA
Lab Invest; 1991 Jul; 65(1):111-20. PubMed ID: 2072661
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
[TBL] [Abstract][Full Text] [Related]
8. Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancer.
Meredith RF; Khazaeli MB; Grizzle WE; Orr RA; Plott G; Urist MM; Liu T; Russell CD; Wheeler RH; Schlom J
Hum Antibodies Hybridomas; 1993 Oct; 4(4):190-7. PubMed ID: 8257773
[TBL] [Abstract][Full Text] [Related]
9. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J
Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
11. Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.
Mangili F; Sassi I; Di Rocco M; Leone BE; Garancini P; Santambrogio G
Cancer; 1996 Dec; 78(11):2334-9. PubMed ID: 8941003
[TBL] [Abstract][Full Text] [Related]
12. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
Simpson J; Schlom J
Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
[TBL] [Abstract][Full Text] [Related]
13. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
[TBL] [Abstract][Full Text] [Related]
14. Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype.
Galietta A; Pizzi C; Pettinato G; Limite G; Sgambato A; Lamberti M; Muraro R; Formisano C; Pensabene M; Bianco AR; Mariani-Costantini R; Contegiacomo A
Oncol Rep; 2002; 9(1):135-40. PubMed ID: 11748471
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: an immunohistochemical study using the monoclonal antibody B72.3.
Roa RA; Hruban RH; McKenzie P; Richtsmeier W
Laryngoscope; 1994 Mar; 104(3 Pt 1):304-8. PubMed ID: 8127187
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and identification of monoclonal antibodies against different epitopes on TAG-72 antigen].
Xu M
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):431-4. PubMed ID: 7515344
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunoreactivity of normal tissues from dogs, using monoclonal antibody B72.3.
Clemo FA; DeNicola DB; Zimmermann JL
Am J Vet Res; 1994 Aug; 55(8):1139-47. PubMed ID: 7978655
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody B72.3 immunostaining of breast carcinoma. Patterns of staining and relationship to mucin content and GCDFP-15 reactivity.
Soomro S; Shousha S
Arch Pathol Lab Med; 1992 Jan; 116(1):32-5. PubMed ID: 1370877
[TBL] [Abstract][Full Text] [Related]
19. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein.
Horan Hand P; Colcher D; Salomon D; Ridge J; Noguchi P; Schlom J
Cancer Res; 1985 Feb; 45(2):833-40. PubMed ID: 3881173
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
Colcher D; Minelli MF; Roselli M; Muraro R; Simpson-Milenic D; Schlom J
Cancer Res; 1988 Aug; 48(16):4597-603. PubMed ID: 3396011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
